Xpert Flu A Panel Test IDs H1N1 in less than 1 hour The FDA has granted Emergency Use Authorization to Cepheid, Sunnyvale, Calif, for its Xpert® Flu A Panel test. The test, which runs on the company’s GeneXpert® System, identifies the 2009
Read MoreOraSure and Roche Sign Commercialization Agreement for Oral Fluid DOA Assays OraSure Technologies Inc and Roche Diagnostics announced that the companies have signed an agreement for the worldwide commercialization of homogeneous fully automated
Read MoreRising consumer awareness that early diagnosis and treatment can delay the progression of human immunodeficiency virus (HIV) to anti-immuno deficiency syndrome (AIDS) has had a telling impact on the sales of HIV tests.
Read More
While molecular assays continue to be the gold standard in accuracy, point-of-care testing also moves to the fore.
Read MoreAspenBio Pharma Inc announces that it has entered into a strategic relationship with LRE Medical GmbH (LRE) to complete commercial development and manufacture of the reader instrument to be used with the AppyScore cassette system.
Read More